stockrowSepterna, Inc. (SEPN) vs Vericel Corporation (VCEL)
- Septerna, Inc. SEPN 49.88 +5.34%
- Vericel Corporation VCEL 54.37 +5.00%
Septerna, Inc. and Vericel Corporation are both Biotechnology companies. Vericel Corporation is the larger, with a market value of $2.7B against $2.2B — 1.2× the size. Septerna, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 77.8×. Septerna, Inc. grew revenue faster over the last twelve months: 13,520.1% against 25.3%. Vericel Corporation has the higher net margin (10.3% vs −24.5%) and the higher return on invested capital (7.88% vs −189.0%). Across the 17 metrics below, Vericel Corporation leads on 10 and Septerna, Inc. on 7.
Valuation
Profitability
| Metric | SEPN | VCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 74.47% | 65.16% |
| Operating margin | (44.04%) | 8.32% | 0.00% |
| Net margin | (24.51%) | 10.27% | 0.00% |
| Free cash flow margin | 118.93% | 17.86% | 0.00% |
| Return on equity | (6.34%) | 9.44% | (50.12%) |
| Return on assets | (4.94%) | 6.86% | (45.60%) |
| Return on invested capital | (189.01%) | 7.88% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack